Tag: process capability

Managing Facility Fit Between Pilot and Commercial Scale Operations Scaling from pilot to commercial manufacturing is a critical phase in pharmaceutical development, fraught with risks that can impact product quality,…

Risks Involved in Sterile Filling During Process Scale-Up and How to Mitigate Them As pharmaceutical companies transition from pilot to commercial scale, numerous risks arise, particularly in sterile filling processes.…

Addressing Coating Defects in Commercial Scale After Successful Pilot Trials Transitioning from pilot-scale to commercial-scale manufacturing often presents unique challenges, particularly regarding coating defects that were not apparent during earlier…

Managing Risks During Tablet Compression Scale-Up from Pilot to Commercial Production In pharmaceutical manufacturing, scale-up from pilot to commercial production presents unique challenges that can jeopardize product integrity and compliance.…

Navigating Tablet Compression Challenges During Scale-Up from Pilot to Commercial Production The transition from pilot to commercial manufacturing can be fraught with risks, particularly when it comes to tablet compression…

Mitigating Risks During Scale-Up of FBD and Tray Dryer Processes In the pharmaceutical manufacturing landscape, transitioning processes from pilot to commercial scale poses inherent risks, particularly when utilizing Fluid Bed…

Managing Risks and Control Strategies in Commercial Scale Granulation Transitioning from pilot to commercial scale in pharmaceutical manufacturing introduces a range of potential risks that can impact product quality, compliance,…

Addressing Commercial Scale Mixing Challenges After Successful Pilot Batches In pharmaceutical manufacturing, transitioning from pilot to commercial scale is a critical phase fraught with challenges. Despite successful pilot batches, commercial-scale…

Translating Pilot CPPs into Commercial Operating Ranges: A Structured Approach Transitioning from pilot to commercial scale can be fraught with challenges. Companies often observe discrepancies in process parameters, yields, and…

Translating Pilot Critical Process Parameters to Commercial Operating Ranges Translating Pilot Critical Process Parameters (CPPs) into effective commercial operating ranges is a common dilemma in pharmaceutical manufacturing. When these parameters…

Addressing the Risks Associated with Batch Size Increases in Pharmaceutical Production Batch size increases during the transition from pilot to commercial-scale manufacturing can introduce several challenges and risks that must…

Identifying and Mitigating Process Capability Risks in Transitioning from Pilot to Commercial Scale The transition from pilot to commercial scale in pharmaceutical manufacturing is fraught with potential risks. During this…